FdaApplication
NDA 217512
Identifiers
- fda_app_no: NDA217512
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2024-02-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | PANTOPRAZOLE SODIUM | EQ 40MG BASE/50ML (EQ 0.8MG BASE/ML) | SOLUTION;INTRAVENOUS |
| PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | PANTOPRAZOLE SODIUM | EQ 40MG BASE/100ML (EQ 0.4MG BASE/ML) | SOLUTION;INTRAVENOUS |
| PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | PANTOPRAZOLE SODIUM | EQ 80MG BASE/100ML (EQ 0.8MG BASE/ML) | SOLUTION;INTRAVENOUS |
3 products